Health Care Costs Projected to Rise 10% in 2026 – IA Magazine

Here comes 2026, and apparently health care costs did not get the memo about “being chill.” The headline figure making the rounds is that health care costs are projected to rise about 10% in 2026, a number popularized by IA Magazine through its coverage of a WTW forecast. That figure is attention-grabbing for a reason: even when other respected forecasts come in a bit lower, the overall message is the same. Medical spending, employer health benefit costs, premiums, pharmacy expenses, and out-of-pocket pressures are all still moving in the wrong direction for households trying to budget and employers trying not to faint in front of their benefits consultant.

The big takeaway is not that every analyst agrees on one magical percentage point. They do not. The big takeaway is that nearly every serious source is waving the same bright red flag: health care inflation is staying stubbornly high, and 2026 is shaping up to be another expensive year for employers, workers, families, and anyone who has ever opened a medical bill and wondered whether it was printed on gold leaf.

Why the “10%” headline matters, even if the exact number varies

The phrase “health care costs projected to rise 10%” works as a headline because it captures the mood of the market. WTW’s estimate for the U.S. sits just under that threshold, at 9.6% for 2026. Mercer’s employer-sponsored plan forecast is lower, projecting a 6.7% increase after employers make cost-cutting changes, while PwC projects an 8.5% medical cost trend for the group market and 7.5% for the individual market. On paper, those are different numbers. In practice, they all point to the same uncomfortable truth: health care costs remain elevated enough to force hard decisions.

That difference in forecasts is not evidence that anyone is confused. It is evidence that they are measuring different things. Some reports track gross medical trend. Some track employer health benefit cost per employee. Some focus on claims experience in group plans, while others reflect broader insurer perspectives. So yes, the numbers vary. But no, that does not make the problem smaller. It makes it more widespread.

In other words, whether your dashboard says 6.7%, 8.5%, or 9.6%, the budget pain is still very real. For benefit managers, brokers, HR leaders, and employees staring down higher payroll deductions, this is less a debate over decimals and more a loud reminder that the system is still under pressure.

What is driving health care costs higher in 2026?

1. Prescription drugs are still a heavyweight cost driver

Pharmacy spending keeps barging into the conversation like it owns the place. And frankly, at this point, it kind of does. Across multiple industry reports, prescription drugs remain one of the clearest reasons health care costs are staying high. Expensive specialty drugs, new therapies, gene and cell treatments, and especially GLP-1 medications for diabetes and weight management are pushing budgets upward.

Mercer flagged GLP-1 utilization as a key cost driver in 2025 and into 2026. PwC reported pharmacy trend running above overall medical trend. AHIP has also emphasized that drug spending is a major driver of premium growth, especially as high-cost therapies enter the market. This is the kind of trend that sounds impressive in a biotech earnings call and much less charming when it shows up in your renewal notice.

GLP-1s deserve special mention because they sit right at the center of the 2026 cost conversation. Employers increasingly see them as both a promising health tool and a budgetary headache. That tension is shaping benefit design right now. Cover them too broadly, and pharmacy costs jump fast. Restrict them too aggressively, and employers risk employee frustration, inequity concerns, and worse long-term health outcomes. It is the policy version of trying to fix a leaky roof while it is still raining.

2. Hospital and labor costs remain stubbornly high

Hospital care is another major source of pressure. The American Hospital Association has shown that hospital expenses continued climbing in 2025, with especially sharp increases in labor, supplies, and drugs. That matters because hospitals sit at the center of so much health spending, from surgeries and emergency care to imaging, specialist visits, and inpatient treatment.

Labor is a huge part of the story. Hospitals and health systems still face workforce shortages, burnout, retention problems, and wage pressure. Even when inflation cools in the broader economy, health care labor costs do not necessarily snap back. A hospital cannot simply put “do more with less” on a motivational poster and suddenly solve nursing shortages. Staff still need to be recruited, trained, scheduled, and retained, and all of that costs money.

The price data shows the same upward tug. Medical care prices rose in 2025, and hospital services posted one of the sharpest increases within that mix. So even before a patient sees more services or more complex care, the underlying price floor is already moving upward. That is how health care bills can feel like they are training for a marathon while wage growth is still tying its shoes.

3. Chronic disease is expensive, common, and not going away

One reason the health care cost problem is so persistent is that it is tied to conditions that are persistent too. Chronic disease, mental health conditions, obesity, cardiovascular disease, diabetes, and multiple long-term conditions account for a massive share of spending in the United States. CDC data makes the point plainly: chronic and mental health conditions drive the overwhelming majority of annual U.S. health care expenditures.

This matters because chronic disease is not a one-time line item. It is recurring. It shows up in primary care, specialty care, medications, diagnostic testing, hospitalizations, and long-term management. An aging population adds another layer, because older patients tend to use more services and have more complex care needs. The result is a system where demand keeps building while affordability keeps shrinking.

That is why experts increasingly argue that prevention, early intervention, and better care navigation are not just “nice wellness ideas.” They are cost strategy. When employers ignore chronic disease management, they often pay for it later in claims, absenteeism, disability costs, and lost productivity.

4. Higher utilization is back, and it is not subtle

For a while, some health spending patterns were distorted by the pandemic and its aftermath. That era is fading. Utilization has been rebounding, and in many categories it is simply normalizing at a high level. CMS projections show that national health spending growth has accelerated in recent years, and part of that reflects stronger use and intensity of services.

Translation: people are using care again, and often they are using more of it. That includes outpatient visits, physician services, diagnostic work, behavioral health care, and prescription treatments. Some of this is good news because delayed care is finally getting addressed. But from a cost perspective, more use plus higher prices equals the kind of math nobody enjoys.

Behavioral health is another important piece of the puzzle. Demand remains elevated, and access is still uneven. That can lead to higher costs downstream when patients cannot get timely, coordinated support. It is one of the reasons many employers are trying to expand navigation tools, virtual options, and integrated mental health support instead of just hoping the claims trend will suddenly decide to become polite.

5. Technology helps, but first it usually sends the bill

One of the more interesting themes in 2026 forecasts is the role of new medical technologies. WTW’s survey found that insurers continue to see new medical technologies as a leading driver of medical inflation. That sounds counterintuitive at first because technology is often sold as a cost saver. Eventually, it can be. In the short term, though, innovation frequently raises costs before it lowers them.

Think of advanced diagnostics, precision treatments, digital monitoring tools, and newer therapeutic classes. They may improve outcomes, speed up diagnosis, or reduce complications in the future. But during the adoption phase, they can add to spending because they are new, expensive, and used alongside existing care instead of immediately replacing it.

Artificial intelligence may eventually streamline administration, reduce duplication, and improve clinical decision-making. But 2026 is still more “investment phase” than “everything is cheaper now” phase. So far, technology is acting less like a coupon and more like a credit-card purchase you hope pays off later.

6. Market concentration reduces the pressure to keep prices down

There is also a structural issue that does not get enough public attention: competition. GAO has found that private health insurance markets remain highly concentrated in many states, and broader policy research continues to highlight hospital and provider consolidation as a major factor behind higher prices. When markets consolidate, the bargaining environment changes. Prices do not always move in a patient-friendly direction.

That helps explain why affordability problems can persist even when the public hears constant talk about efficiency, disruption, digital transformation, and every other buzzword consultants lovingly place in slide decks. A market can become more technologically advanced and still remain very expensive if competition is weak and pricing power is concentrated.

What rising 2026 health care costs mean for employers and workers

For employers, the first consequence is obvious: bigger benefit budgets. The second consequence is harder: deciding how to absorb those costs. Many employers have already spent years trying not to shift too much burden onto workers because affordability is a recruitment and retention issue. But when costs keep climbing, that restraint gets harder to maintain.

KFF’s latest employer data shows why this matters. Employer-sponsored family coverage already costs a lot, workers already contribute thousands of dollars toward those premiums, and deductibles remain substantial. Over time, premiums have risen faster than many households would describe as “comfortably manageable,” which is corporate language for “people are sweating in the parking lot before open enrollment.”

Workers feel the squeeze in more than one place. They may pay more in premiums, face higher deductibles, encounter narrower networks, or deal with tighter utilization management. Just under half of adults say it is difficult to afford health care costs, and a sizable share report trouble paying medical bills. That means rising costs are not an abstract employer-finance issue. They land directly in family budgets.

The self-insured and individual markets face their own complications too. CMS and KFF data show that 2026 marketplace dynamics are being shaped by premium changes and reduced subsidy support compared with the enhanced tax-credit era. Some consumers may still find attractive options, especially with tax credits. Others, particularly middle-income households and some older adults, may feel much sharper premium pain.

The result is a split-screen health economy. On one side, more medical innovation, more treatment options, and more ways to access care. On the other, more cost anxiety, more benefit tradeoffs, and more households asking whether “covered” still means “affordable.”

What smart organizations can do next

There is no magical reset button for health care inflation, but there are smarter ways to respond than simply passing the bill to employees and hoping nobody notices. The better strategies in 2026 are likely to be targeted, not blunt.

First, employers can get more disciplined about pharmacy management. That means looking carefully at GLP-1 coverage rules, prior authorization, site-of-care policies, specialty drug management, and patient support programs. The goal is not to block access blindly. The goal is to pay for appropriate care in a way that does not set the budget on fire.

Second, organizations can invest in high-value care navigation. Steerage to quality providers, centers of excellence, virtual-first pathways where appropriate, and better primary care access can help reduce avoidable emergency and specialty spending. That is not glamorous, but neither is an unnecessary hospital bill.

Third, prevention and chronic disease management need to be treated like real financial strategy. Better support for diabetes, hypertension, cardiovascular risk, obesity, and behavioral health may not slash costs overnight, but it can improve outcomes and reduce downstream claims pressure over time.

Finally, transparency matters. Employees make better decisions when they understand what is covered, what is not, where lower-cost options exist, and how to avoid surprise bills. Confused members are not cost-efficient members. They are just stressed members with a login they forgot three password resets ago.

Composite experiences from the cost front lines

Note: The experiences below are composite examples based on common patterns reflected in current employer surveys, affordability research, and 2026 cost-trend reporting.

The HR director: Melissa runs HR for a 220-person manufacturing company in the Midwest. She is not anti-benefits. In fact, she likes being the person who can tell employees that the company still covers a big share of premiums. But this year, her renewal meeting felt like an ambush. Pharmacy costs were up, specialty claims were up, and the broker walked in with that careful “let’s talk about options” voice that always means nobody will enjoy the options. Melissa spent three weeks comparing plan designs, trying to avoid raising deductibles too sharply. In the end, the company adjusted contributions, tightened a few coverage rules, and added a navigation tool. Employees were relieved it was not worse. Melissa was relieved nobody threw a stapler.

The employee with a chronic condition: James has employer coverage, a decent salary, and type 2 diabetes. On paper, he is exactly the kind of person people assume is “doing fine.” In real life, he still notices every formulary change. His medication works, but every January feels like a scavenger hunt through prior authorizations, preferred drug lists, and specialty pharmacy phone trees. When people say health care costs are rising, James hears something more specific: more paperwork, more uncertainty, and more moments where staying healthy feels weirdly administrative. He does not just need care. He needs coverage that behaves like it remembers he is a human being.

The self-employed couple: Tara and Ben buy their own coverage. They are not uninsured, and they are not reckless. They are just self-employed and permanently one spreadsheet away from muttering at their kitchen table. In 2026, the premium quote arrives, and their first reaction is silence. Their second reaction is math. They compare plans, check subsidies, review deductibles, and debate whether the cheaper premium is worth the narrower network. They joke that selecting health insurance now requires the emotional resilience of a hostage negotiator. The joke is funny because it is not entirely a joke.

The benefits consultant: Andre spends his days explaining to employers why the trend line is ugly but not identical across every report. He has become fluent in the language of “gross trend,” “net cost,” “mitigation strategy,” and “high-cost claimant volatility.” What he really wants to say is simpler: every part of the system is leaning on every other part. Drug costs push premiums. Labor pressure pushes provider pricing. Chronic disease pushes utilization. Consumers delay care because of cost, then later need more expensive care. Employers want generosity without runaway spending. Employees want affordability without barriers. Everyone is trying to solve a puzzle where the pieces keep billing each other.

These experiences matter because they reveal what statistics alone cannot. A 9.6% forecast is not just a macroeconomic talking point. It is a smaller raise after deductions. It is a more tense renewal season. It is a family switching plans, an employee delaying a refill, or an HR team trying to keep benefits competitive without turning the finance department into a haunted house.

Conclusion

So, are health care costs really projected to rise 10% in 2026? The most honest answer is this: one highly visible forecast says U.S. costs will rise 9.6%, while other respected projections are somewhat lower but still uncomfortably high. That does not weaken the story. It strengthens it. The evidence across the market points in the same direction: 2026 will be another expensive year for medical care, health insurance, employers, and consumers.

The drivers are now familiar but no less serious: costly drugs, high hospital expenses, chronic disease, rising utilization, new technologies, and structural pricing pressure. The organizations that handle 2026 best will not be the ones pretending the trend is temporary. They will be the ones designing smarter benefits, steering people to better-value care, and treating affordability like a strategy instead of a slogan. Because when health care costs keep climbing, “wait and see” is not a plan. It is just expensive procrastination wearing a necktie.